Several guidelines are against using PSA test based screening for PCa; the US Preventive Services task force, the Canadian task force on preventive health and the American College of Preventive Medicine do not currently recommend PSA-based testing due to insufficient evidence.90–92 This has made it difficult, so far, to convince policymakers to adopt PCa screening programme. This evidence concerns the gene KLK3 and posterior cortical atrophy.